Publication: Dexamethasone in Cerebral Malaria
Issued Date
1982-07-29
Resource Type
ISSN
15334406
00284793
00284793
Other identifier(s)
2-s2.0-0019965613
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
New England Journal of Medicine. Vol.307, No.5 (1982), 317-319
Suggested Citation
Anthony Hall, D. W. Macpherson, Stephen L. Hoffman, Y. Naparstek, D. Weiler-Ravell, J. Shemer, D. Englehard, J. Sack, J. Adler, David A. Warrell, Sornchai Looareesuwan, M. J. Warrell, Danai Bunnag, Tranakchit Harinasuta Dexamethasone in Cerebral Malaria. New England Journal of Medicine. Vol.307, No.5 (1982), 317-319. doi:10.1056/NEJM198207293070518 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/30390
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dexamethasone in Cerebral Malaria
Abstract
To the Editor: I congratulate Warrell et al. (February 11 issue) for their important controlled study of coma due to falciparum malaria, which showed that dexamethasone increased the duration of coma and the incidence of complications.1The low overall fatality rate of 17 per cent is noteworthy and a reflection of the quality of treatment. The authors did not state how many patients became comatose after entering the hospital and after receiving treatment with intravenous infusions of quinine. Quinine can cause coma,2and as can fluid overload2(possibly because of cerebral edema) and pulmonary edema; the latter developed in 10. © 1982, Massachusetts Medical Society. All rights reserved.